

Our Purpose and Core Values
All our activities are based on out corporate philosophy, wchic consists of Our Purpose and Our Core Values.
OUR PURPOSE
Making people's lives healthier, safer and more fulfilling
OUR CORE VALUES
Patient Focus: We put patients at the heart of everything
Integrity: We do the right thing
Innovation: We look for new ways to make things better
Impact: We take accountability and get things done
Empathy: Wecare for one another and work together
What makes us proud at Olympus?
Supporting cutting-edge medical procedures, advancing ever forward to be a company esteemed by all stakeholders for its quality and innovation. But it’s not just what we do, it’s how we do it. We put patients at the heart of everything. In maintaining our patient focus, we diligently consider the realities faced by patients, customers, and healthcare systems in developing meaningful solutions. Striving to defy convention and stay ahead of the curve, we continuously try new things. For the sake of innovation that improves patient lives, we look for new ways to make things better. Embracing ownership of our work and fostering cooperation across functions and regions is essential to keep delivering value to society and make an impact. We take accountability and get things done. Collaborations flourish when we treat all individuals with respect and invite diverse perspectives, demonstrating empathy. We care for one another and work together. And we earn the trust and confidence of others by delivering excellence and high quality and learning from our mistakes. To embody integrity in our every interaction, we do the right thing. This is how we make people’s lives healthier, safer and more fulfilling.
Learn more in detail about the products by visiting the "Devices" tab.

A surgical perspective on minimizing NMIBC recurrence. Dr. Teoh addresses the limitations of conventional TURBT and discusses the integration of 4K imaging and bipolar plasma energy platforms to facilitate en-bloc resection (ERBT). The lecture details step-by-step techniques for mucosal incision and blunt dissection down to the detrusor muscle, supported by recent randomized controlled trials and the progress of the global ERBT registry.
Published
Aug 2026

Dr. Gudbrandsdottir analyzes the complementary clinical applications of Narrow Band Imaging (NBI) and Photodynamic Diagnosis (PDD). Utilizing data from recent European multicenter trials, the session explores how enhanced imaging technologies influence surgical decisions and impact recurrence-free survival rates. The presentation also provides practical operating room troubleshooting tips for managing bleeding, air bubbles, and false positives.
Published
Aug 2026

A clinical and scientific examination of Narrow Band Imaging (NBI) technology in bladder cancer management. Dr. Bochner details the biophysical mechanism of NBI, focusing on how the 415 nm and 540 nm wavelengths match hemoglobin absorption to highlight vascularization. The session reviews key clinical trial data on tumor detection sensitivity and showcases real cystoscopic comparisons of papillary and flat (CIS) lesions under white light versus NBI.
Published
Aug 2026
Join leading global experts for an exclusive scientific program dedicated to optimizing clinical outcomes in Non-Muscle-Invasive Bladder Cancer (NMIBC). This specialized session will delve into the latest guidelines, visual detection advancements like NBI and PDD, and future strategies to prevent recurrence. Don't miss this opportunity to gain valuable insights from international key opinion leaders, explore precision treatment pathways, and participate in an interactive panel discussion designed to elevate patient care standards. Welcome and Introduction: Guidelines, challenges and strategies for optimized NMIBC diagnosis and treatment - by Dr. Gígja Gudbrandsdottir (Norway) Improving Visual Detection for NMIBC Diagnosis - How NBI helps me improving clinical outcomes - Dr. Bernard H. Bochner (USA) Optimizing diagnostic strategy in NMIBC: Complementary use of NBI and PDD for precision treatment pathway - Dr. Gígja Gudbrandsdottir (Norway) Preventing NMIBC recurrence: Patient care strategy and future development - Dr. Jeremy Teoh (Hong Kong) Panel Discussion & Closing Remarks
Published
Jun 2026
Share it with your network and help spread clinical knowledge.